Refractory Epilepsy clinical trials

Explore recruiting refractory epilepsy clinical trials.

Recruiting refractory epilepsy studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Refractory Epilepsy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Cannabidiol in refractory childhood epilepsy, a personalized high-quality approach

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Double-Blind, Randomized, Placebo and Active Controlled Study to Evaluate the Efficacy and Safety of Once Daily, Extended Release Levetiracetam as Add-on Therapy in Patients with Refractory Partial Onset Epilepsy.

Poland, Romania, Germany, Czechia, Bulgaria, Italy +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Treatment with full-spectrum cannabis extract of refractory epilepsy associated with Tuberous Sclerosis Complex (TSC): SPECTRUM

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase I, open-label clinical trial to evaluate the safety and clinical response of repeated-dose intra-arterial infusion of autologous mesenchymal cells in children and adolescents with refractory epilepsies.

Spain

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Three-part PK and PD study of AXN-027

Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

Refractory Epilepsy trials by city

Refractory Epilepsy clinical trials

Recruiting refractory epilepsy studies right now

Subthalamic Nucleus Electrical Stimulation for Drug-resistant Focal Motor Epilepsy

Diagnosing Epilepsy To EffeCT Change

A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy

Neural Mechanisms of Spatial Representations Beyond the Self

Low Intensity Focused Ultrasound Epilepsy: A Pilot Trial

Ketogenic Diet for Prevention of Epileptic Spasms in Infantile Onset Genetic Epilepsies

Temporal Interference for Drug Resistant Epilepsy

Biomarkers of Response to SEEG Thermocoagulation

MEG Versus EEG HR for the Localization of the Epileptogenic Zone as Part of the Pre-surgical Assessment of Epilepsy

Placebo Controlled Study to Assess the Efficacy and Safety of Rapamycin in Drug Resistant Epilepsy Associated With Tuberous Sclerosis Complex

Feasibility Study of the iVEAcare Neuromodulation System for the Treatment of Drug-Resistant Epilepsy

Hybrid Micro-macro Electrodes in Patients With Epilepsy

Also recruiting in Europe

Cannabidiol in refractory childhood epilepsy, a personalized high-quality approach

A Double-Blind, Randomized, Placebo and Active Controlled Study to Evaluate the Efficacy and Safety of Once Daily, Extended Release Levetiracetam as Add-on Therapy in Patients with Refractory Partial Onset Epilepsy.

Treatment with full-spectrum cannabis extract of refractory epilepsy associated with Tuberous Sclerosis Complex (TSC): SPECTRUM

Phase I, open-label clinical trial to evaluate the safety and clinical response of repeated-dose intra-arterial infusion of autologous mesenchymal cells in children and adolescents with refractory epilepsies.

Three-part PK and PD study of AXN-027

Refractory Epilepsy trials by city

Other conditions